Finance Watch: Kallyope Leads Latest Group Of VC Mega-Rounds With $236m Raise
Series D Cash Will Fund Gut-Brain Axis Drug Trials
Private Company Edition: In other $100m-plus venture capital rounds, Third Harmonic Bio emerged with $155m, including a new $105m series B round. Also, Europe- and Japan-focused Newton Biocapital launched its second VC fund with €50m in initial capital and a €150m fundraising goal.
